Atrial Fibrillation Division; Inc.;St. Jude Medical
发明人:
Karin Jarverud,Cecilia Emmanuelsson,Anders Bjorling,Kjell Noren
申请号：
US14933112
公开号：
US20160059035A1
申请日:
2015.11.05
申请国别(地区):
US
年份:
2016
代理人:
摘要：
In response to local or systemic inflammation in a patient, photobiomodulation therapy is applied to a cardiac location to reduce the risk and/or occurrence of cardiac arrhythmia. Once inflammation is identified, photobiomodulation therapy can be applied in any suitable fashion (e.g., via a catheter- or transesophageal probe-mounted photoemitter, via an externally-applied photoemitter, or via photoemitter incorporated into an implantable medical device). Photobiomodulation therapy can also be employed to good advantage in conjunction with non-photobiomodulation therapy (e.g., traditional cardiac rhythm management therapies).
